04/11/2023 / By Ethan Huff
A pharmaceutical drug that murders unborn babies will no longer be publicly available as of this Friday, thanks to a preliminary injunction imposed by U.S. District Judge Matthew Kacsmaryk of Texas, a Donald Trump appointee.
Despite being on the market for more than two decades, mifepristone, which halts normal fetal development, will no longer be allowed for prescription. Without it, the other part of the two-drug regimen needed to fully terminate a pregnancy will no longer work to complete an abortion.
The move came in response to a lawsuit that aims to seek a more permanent ban on the drug. For now, the drug will be blocked, but there is still a chance that mifepristone once again becomes available in the future.
We are told that the U.S. Food and Drug Administration (FDA) will now have the opportunity to appeal Kacsmaryk’s decision before it comes into effect. Chances are the Biden regime will take full advantage of this appeal opportunity.
Should that occur, the decision will be handed over to the New Orleans-based 5th Circuit Court of Appeals, which is considered to be one of the most conservative courts in America.
(Related: Did you know that RU-486, another popular abortion pill, was first developed as an extermination tool in Nazi death camps?)
As you might expect, Kacsmaryk’s decision immediately triggered a nationwide meltdown among liberals who seem to have a morbid obsession with murdering unborn children.
After the media branded the decision “unprecedented,” Thomas Rice, another U.S. District Judge out of Washington state who was appointed by Barack Hussein Obama, granted a request by several left-leaning “blue” states for an order affirming the FDA’s approval of mifepristone.
With that affirmation in hand, these blue states plan to continue ordering mifepristone so their abortion mills can continue operating unaffected.
Numerous religious groups and pro-life advocates took aim at the FDA with a lawsuit claiming the agency fast-tracked its approval for mifepristone in 2020 without sufficient scientific evidence to back its safety and efficacy.
Notably, the FDA did the exact same thing with Wuhan coronavirus (Covid-19) “vaccines,” which were fast-tracked by the Trump administration via Operation Warp Speed.
Conversely, numerous mainstream medical groups are defending the drug, claiming it is safer than Tylenol and Viagra – though, admittedly, not for the baby. Fewer pregnant women who take mifepristone end up in the hospital for complications compared to users of Tylenol and Viagra, we are told.
Kacsmaryk, who is based out of Amarillo, agrees that the FDA stepped outside the bounds of its authority in approving mifepristone at warp speed, further suggesting the agency “faced significant political pressure” to get the drug to market as quickly as possible.
“The Court does not second-guess FDA’s decision-making lightly,” Kacsmaryk said in his decision.
“But here, FDA acquiesced on its legitimate safety concerns – in violation of its statutory duty – based on plainly unsound reasoning and studies that did not support its conclusions.”
Kacsmaryk went on in his decision to claim that the FDA’s warp speed approval of mifepristone at the turn of the century has likely led to many injuries and deaths among women who took the drug to kill their unborn children.
“Whatever the numbers are, they likely would be considerably lower had FDA not acquiesced to the pressure to increase access to chemical abortion at the expense of women’s safety,” he further wrote.
The latest news about the left-right fight over abortion and the “right” to murder unborn children can be found at Genocide.news.
Sources for this article include:
Tagged Under:
This article may contain statements that reflect the opinion of the author
BadMedicine.News is a fact-based public education website published by BadMedicine News Features, LLC.
All content copyright © 2019 by BadMedicine News Features, LLC.
Contact Us with Tips or Corrections
All trademarks, registered trademarks and servicemarks mentioned on this site are the property of their respective owners.